Navigation Links
InBios' Dengue IgM ELISA Continues to Prove Fast and Effective for Presumptive Diagnosis of Dengue Virus Infection
Date:8/27/2013

Seattle, WA (PRWEB) August 27, 2013

A new study conducted by researchers at the John A. Burns School of Medicine, University of Hawaii, evaluated the InBios DENV Detect IgM Capture ELISA for qualitative detection of IgM antibodies to dengue virus recombinant antigens (1). Well characterized clinical serum samples collected from Hawaii, Vietnam, Niue, Singapore and American Samoa were tested with the DENV Detect IgM Capture ELISA in comparison with in-house DENV IgM antibody capture (MAC) ELISA. The agreement, sensitivity, and specificity of the InBios assay were 94, 92 and 94% respectively. The study found that InBios’ DENV Detect IgM Capture ELISA is advantageous compared to the in-house MAC-ELISA, as the results can be obtained in less than 5 hours, whereas the in-house MAC-ELISA requires 2 to 3 days.

The study, titled “Evaluation of a New Commercially Available Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Diagnosis of Dengue Virus Infection,” was published in the Journal of Clinical Microbiology, July 2013;51(9):3102-6.

This study was supported in part by grants P20GM103516, U01AI078213 and U54MD007584 from the National Institutes of Health, grant W81XWH0720073 from the Department of Defense and by institutional funds.

About Dengue:

Dengue is a significant human pathogen of global importance. Today about 2.5 billion people, or 40% of the world’s population, live in areas where there is a risk of dengue transmission. Dengue is endemic in at least 100 countries in Asia, the Pacific, the Americas, Africa and the Caribbean. The World Health Organization (WHO) estimates that 50 to 100 million infections occur yearly, including 500,000 DHF cases and 22,000 deaths, mostly among children (4). Recently there have been reported outbreaks in Kenya (May 2013) and Angola (June 2013) (2). Although most of the reported cases in the Unites States are acquired by travelers or immigrants, autochthonous dengue fever outbreaks have occurred in Brownsville, TX (2005), southern Florida (2009-2011) and Hawaii (2011) (3).

About InBios International, Inc.:

InBios International, Inc., located at 562 1st Ave. South, Suite 600, Seattle, WA, USA, manufactures diagnostic tests for infectious diseases. InBios is an FDA registered facility and ISO 13485:2003 Certified. The company manufactures a full range of dengue products including ELISA kits for Dengue IgM, IgG, and NS1 and a rapid test for Dengue NS1. All products are manufactured in the USA.

References:
(1)    Namekar M, Ellis EM, O’Connell M, Elm J, Gurary A, Park SY, Imrie A and Nerurkar VR. Evaluation of a New Commercially Available Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Diagnosis of Dengue Virus Infection. J Clinical Microbiol. 2013; 51:3102.
(2)    http://www.cdc.gov/dengue/travelOutbreaks/
(3)    Bouri N, Kirk Sell T, Franco C, Adalja AA, Henderon DA and Hynes NA. Return of Epidemic Dengue in the Unites States: Implications for the Public Health Practitioner. Public Health Rep. 2012;127:259.
(4)    http://www.cdc.gov/dengue/epidemiology/

Read the full story at http://www.prweb.com/releases/2013/8/prweb11058705.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New findings could influence the development of therapies to treat dengue disease
2. NTU designs social media and web system that can predict dengue hotspots
3. Mast cells give clues in diagnosis, treatment of dengue
4. Warning system predicts outbreaks of dengue fever
5. La Jolla Institutes surprising finding could alter the face of dengue vaccine development
6. Global burden of dengue is triple current estimates
7. Homegrown Strain of Dengue Fever Virus Pinpointed in Florida
8. Tracking the spread of dengue fever: Domestic networks drive rapid transmission of human infection
9. NIH-developed candidate dengue vaccine shows promise in early-stage trial
10. Experimental Dengue Vaccine Shows Some Success
11. Dengue Vaccine Initiative welcomes latest progress in vaccine development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... Hospital M&A activity slowed in the ... number of hospital acquisitions rose to 23 in the second quarter, up 15% from ... from the 20 announced deals in the year-ago second quarter. Only four of the ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... a $5,000 grant from the C. R. Bard Foundation, Inc. to ... Somerset Hills , a service available through the nonprofit home care agency. Using ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to ... PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network of ... in dermatology, skin cancer , and more. She graduated from the University of ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set of transitions ... timeline. This effect isolates horizontal and vertical lines of pixels and sorts their pixels ... or flipping animation and can be changed using a drop-down menu. Create amazing and ...
(Date:7/20/2017)... Houston, Texas (PRWEB) , ... July 20, 2017 ... ... and litigation law firm headquartered in Houston, is pleased to announce their expansion ... decades of affordable housing experience, directors Alysse Hollis and Ronald Bell, and of ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... -- Endo International plc (NASDAQ: ENDP ) will announce ... of its senior management team will host a conference call and ... The dial-in number to access the call is ... the passcode is 45397076. Please dial in 10 minutes prior to ... A replay of the call will be available from August 8, ...
(Date:7/13/2017)... 13, 2017  New York City-based market research firm Kalorama ... be aware of.  From new products to new costs, to ... a recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment ... of the impact the growing population and, to a more ...
(Date:7/11/2017)... WHIPPANY, N.J. , July 11, 2017  Bayer has ... across eight countries as part of its prestigious Bayer Hemophilia ... Children,s Hospital of Philadelphia and Uniformed ... are among the winners. Grant recipients were announced ... Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
Breaking Medicine Technology: